glp-1 neuroendocrine tumor Glucagon-like peptide 1 receptor agonists and cancer risk: advancing precision medicine through mechanistic understanding and clinical evidence | Biomarker Research When Should Patients with NETs

glp-1 neuroendocrine tumor

glp-1 neuroendocrine tumor Glucagon-like peptide 1 receptor agonists and cancer risk: advancing precision medicine through mechanistic understanding and clinical evidence | Biomarker Research When Should Patients with NETs

Name: glp-1 neuroendocrine tumor Glucagon-like peptide 1 receptor agonists and cancer risk: advancing precision medicine through mechanistic understanding and clinical evidence | Biomarker Research When Should Patients with NETs
Brand: shamsengineering.com
SKU: 229049320
Price: 27.11 USD
Availability: InStock
Rating: 4.3636 (27 reviews)

SKU: 229049320

4.4

USD27.11 USD50.11

Pay in 4 interest-free payments of $6.78 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 8 - Aug 13

Description

Various lab tests help identify the cause underlying symptoms associated with uremia (a high level of waste products in the blood due to kidney failure)